Cardiovascular consequences of sleep-disordered breathing: Contribution of animal models to understanding of the human disease

ILAR Journal

Volumn 50, Issue 3, 2009, Pages 262-281

  Dematteis, Maurice ^a,b   Godin Ribuot, Diane ^a   Arnaud, Claire ^a   Ribuot, Christophe ^a   Stanke Labesque, Françoise ^a,b   Pépin, Jean Louis ^a,b   Lévy, Patrick ^a,b  

^a University Grenoble Alpes   (France)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Atherosclerosis; Cardiovascular remodeling; Hypertension; Inflammation; Intermittent hypoxia; Myocardial infarction; Pre postconditioning; Sleep apnea

Indexed keywords

ANIMALIA;

ANIMAL; ANOXIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CELL LINE; DISEASE MODEL; DOG; HUMAN; MINIPIG; MOUSE; PATHOPHYSIOLOGY; RAT; REVIEW; SLEEP APNEA SYNDROME; SPRAGUE DAWLEY RAT; SWINE;

ANIMALS; ANOXIA; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CELL LINE; DISEASE MODELS, ANIMAL; DOGS; HUMANS; MICE; RATS; RATS, SPRAGUE-DAWLEY; SLEEP APNEA SYNDROMES; SWINE; SWINE, MINIATURE;

EID: 67749113674     PISSN: 10842020     EISSN: None     Source Type: Journal    
DOI: 10.1093/ilar.50.3.262     Document Type: Review

References (242)

1. AASM [American Academy of Sleep Medicine] Task Force. 1999. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667-689.
2. Alchanatis M, Tourkohoriti G, Kosmas EN, Panoutsopoulos G, Kakouros S, Papadima K, Gaga M, Jordanoglou JB. 2002. Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome. Eur Respir J 20:1239-1245.
3. Allahdadi KJ, Walker BR, Kanagy NL. 2005. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 45:705-709.
4. Allahdadi KJ, Cherng TW, Pai H, Silva AQ, Walker BR, Nelin LD, Kanagy NL. 2008a. Endothelin type A receptor antagonist normalizes blood pressure in rats exposed to eucapnic intermittent hypoxia. Am J Physiol Heart Circ Physiol 295:H434-H440.
5. Allahdadi KJ, Duling LC, Walker BR, Kanagy NL. 2008b. Eucapnic intermittent hypoxia augments endothelin-1 vasoconstriction in rats: Role of PKCdelta. Am J Physiol Heart Circ Physiol 294:H920-H927.
6. Almendros I, Acerbi I, Puig F, Montserrat JM, Navajas D, Farré R. 2007. Upper-airway inflammation triggered by vibration in a rat model of snoring. Sleep 30:225-227.
7. Arnaud C, Béguin PC, Dematteis M, Pelli G, Miguet N, Burger F, Ribuot C, Mach F, Lévy P. 2008a. Intermittent hypoxia induces inflammatory vascular remodeling in C57bl6 mice. Am J Resp Crit Care Med 177:A291.
8. Arnaud C, Cachot S, Miguet N, Lévy P. 2008b. Chronic intermittent hypoxia accelerates atherosclerotic plaque formation in ApoE knockout mice independently of cholesterol levels. Eur Resp J 32 suppl 52:484s.
9. Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. 2005. Association of sleep-disordered breathing and the occurrence of stroke. Am J Resp Crit Care Med 172:1447-1451.
10. Asemu G, Papousek F, Ostádal B, Kolár F. 1999. Adaptation to high altitude hypoxia protects the rat heart against ischemia-induced arrhythmias: Involvement of mitochondrial K(ATP) channel. J Mol Cell Cardiol 31:1821-1831.
11. Baekey DM, Feng P, Decker MJ, Strohl KP. 2009. Breathing and sleep: Measurement methods, genetic influences, and developmental impacts. ILAR J 50:248-261.
12. Baguet JP, Hammer L, Lévy P, Pierre H, Launois S, Mallion JM, Pépin JL. 2005a. The severity of oxygen desaturation is predictive of carotid wall thickening and plaque occurrence. Chest 128:3407-3412.
13. Baguet JP, Hammer L, Lévy P, Pierre H, Rossini E, Mouret S, Ormezzano O, Mallion JM, Pépin JL. 2005b. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 23:521-527.
14. Baguet JP, Lévy P, Barone-Rochette G, Tamisier R, Pierre H, Peeters M, Mallion JM, Pépin JL. 2008. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens 26:885-892.
15. Bakehe M, Miramand JL, Chambille B, Gaultier C, Escourrou P. 1995. Cardiovascular changes during acute episodic repetitive hypoxic and hypercapnic breathing in rats. Eur Respir J 8:1675-1680.
16. Bao G, Metreveli N, Li R, Taylor A, Fletcher EC. 1997a. Blood pressure response to chronic episodic hypoxia: Role of the sympathetic nervous system. J Appl Physiol 83:95-101.
17. Bao G, Randhawa PM, Fletcher EC. 1997b. Acute blood pressure elevation during repetitive hypocapnic and eucapnic hypoxia in rats. J Appl Physiol 82:1071-1078.
18. Bao G, Metreveli N, Fletcher EC. 1999. Acute and chronic blood pressure response to recurrent acoustic arousal in rats. Am J Hypertens 12:504-510.
19. Baumgardner JE, Otto CM. 2003. In vitro intermittent hypoxia: Challenges for creating hypoxia in cell culture. Respir Physiol Neurobiol 136:131-139.
20. Béguin PC, Joyeux-Faure M, Godin-Ribuot D, Lévy P, Ribuot C. 2005. Acute intermittent hypoxia improves rat myocardium tolerance to ischemia. J Appl Physiol 99:1064-1069.
21. Béguin PC, Belaidi E, Godin-Ribuot D, Lévy P, Ribuot C. 2007. Intermittent hypoxia-induced delayed cardioprotection is mediated by PKC and triggered by p38 MAP kinase and Erk1/2. J Mol Cell Cardiol 42:343-351.
22. Belaidi E, Béguin PC, Lévy P, Ribuot C, Godin-Ribuot D. 2008. Prevention of HIF-1 activation and iNOS gene targeting by low-dose cadmium results in loss of myocardial hypoxic preconditioning in the rat. Am J Physiol Heart Circ Physiol 294:H901-H908.
23. Belaidi E, Joyeux-Faure M, Ribuot C, Launois SH, Lévy P, Godin-Ribuot D. 2009. Major role for hypoxia inducible factor-1 and the endothelin system in promoting myocardial infarction and hypertension in an animal model of obstructive sleep apnea. J Am Coll Cardiol 53:1309-1317.
24. Belozeroff V, Berry RB, Sassoon CS, Khoo MC. 2002. Effects of CPAP therapy on cardiovascular variability in obstructive sleep apnea: A closed-loop analysis. Am J Physiol Heart Circ Physiol 282:H110-H121.
25. Bonsignore MR, Parati G, Insalaco G, Marrone O, Castiglioni P, Romano S, Di Rienzo M, Mancia G, Bonsignore G. 2002. Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome. Am J Resp Crit Care Med 166:279-286.
26. Bonsignore MR, Parati G, Insalaco G, Castiglioni P, Marrone O, Romano S, Salvaggio A, Mancia G, Bonsignore G, Di Rienzo M. 2006. Baroreflex control of heart rate during sleep in severe obstructive sleep apnoea: Effects of acute CPAP. Eur Respir J 27:128-135.
27. Bradley TD, Floras JS. 2009. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 373:82-93.
28. Braga VA, Soriano RN, Machado BH. 2006. Sympathoexcitatory response to peripheral chemoreflex activation is enhanced in juvenile rats exposed to chronic intermittent hypoxia. Exp Physiol 91:1025-1031.
29. Braunersreuther V, Steffens S, Arnaud C, Pelli G, Burger F, Proudfoot A, Mach F. 2008. A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice. Arterioscler Thromb Vasc Biol 28:1090-1096.
30. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Phillipson EA. 1997. Obstructive sleep apnea as a cause of systemic hypertension: Evidence from a canine model. J Clin Invest 99:106-109.
31. Brooks D, Horner RL, Floras JS, Kozar LF, Render-Teixeira CL, Phillipson EA. 1999. Baroreflex control of heart rate in a canine model of obstructive sleep apnea. Am J Respir Crit Care Med 159:1293-1297.
32. Brown AM, Saum WR, Tuley FH. 1976. A comparison of aortic baroreceptor discharge in normotensive and spontaneously hypertensive rats. Circ Res 39:488-496.
33. Brzecka A. 2005. Brain preconditioning and obstructive sleep apnea syndrome. Acta Neurobiol Exp 65:213-220.
34. Burtscher M, Haider T, Domej W, Linser T, Gatterer H, Faulhaber M, Pocecco E, Ehrenburg I, Tkatchuk E, Koch R, Bernardi L. 2009. Intermittent hypoxia increases exercise tolerance in patients at risk for or with mild COPD. Respir Physiol Neurobiol 165:97-103.
35. Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, Zweier JL, Semenza GL. 2003. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108:79-85.
36. Cai Z, Zhong H, Bosch-Marce M, Fox-Talbot K, Wang L, Wei C, Trush MA, Semenza GL. 2008. Complete loss of ischaemic preconditioninginduced cardioprotection in mice with partial deficiency of HIF-1 alpha. Cardiovasc Res 77:463-470.
37. Campen MJ, Shimoda LA, O'Donnell CP. 2005. Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice. J Appl Physiol 99:2028-2035.
38. Carley DW, Radulovacki M. 1999. Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat. Am J Respir Crit Care Med 160:1824-1829.
39. Carley DW, Trbovic SM, Radulovacki M. 1998. Diazepam suppresses sleep apneas in rats. Am J Respir Crit Care Med 157:917-920.
40. Carley DW, Berecek K, Videnovic A, Radulovacki M. 2000. Sleepdisordered respiration in phenotypically normotensive, genetically hypertensive rats. Am J Respir Crit Care Med 162:1474-1479.
41. Carlson JT, Hedner JA, Sellgren J, Elam M, Wallin BG. 1996a. Depressed baroreflex sensitivity in patients with obstructive sleep apnea. Am J Respir Crit Care Med 154:1490-1496.
42. Carlson JT, Rångemark C, Hedner JA. 1996b. Attenuated endotheliumdependent vascular relaxation in patients with sleep apnoea. J Hypertens 14:577-584.
43. Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH. 2007. Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: Molecular, cellular, and vascular behavior. J Am Coll Cardiol 49:2379-2393.
44. Chen L, Einbinder E, Zhang Q, Hasday J, Balke CW, Scharf SM. 2005. Oxidative stress and left ventricular function with chronic intermittent hypoxia in rats. Am J Respir Crit Care Med 172:915-920.
45. Chen LM, Kuo WW, Yang JJ, Wang SG, Yeh YL, Tsai FJ, Ho YJ, Chang MH, Huang CY, Lee SD. 2007. Eccentric cardiac hypertrophy was induced by long-term intermittent hypoxia in rats. Exp Physiol 92:409-416.
46. Chen L, Zhang J, Gan TX, Chen-Izu Y, Hasday JD, Karmazyn M, Balke CW, Scharf SM. 2008. Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxia. J Appl Physiol 104:218-223.
47. Choi JB, Loredo JS, Norman D, Mills PJ, Ancoli-Israel S, Ziegler MG, Dimsdale JE. 2006. Does obstructive sleep apnea increase hematocrit? Sleep Breath 10:155-160.
48. Claustre J, Peyrin L. 1982. Free and conjugated catecholamines and metabolites in cat urine after hypoxia. J Appl Physiol 52:304-308.
49. Cooper VL, Bowker CM, Pearson SB, Elliott MW, Hainsworth R. 2004. Effects of simulated obstructive sleep apnoea on the human carotid baroreceptor- vascular resistance reflex. J Physiol 557:1055-1065.
50. Coughlin SR, Mawdsley L, Mugarza JA, Wilding JP, Calverley PM. 2007. Cardiovascular and metabolic effects of CPAP in obese males with OSA. Eur Respir J 29:720-727.
51. Deegan PC, McNicholas WT. 1995. Pathophysiology of obstructive sleep apnoea. Eur Respir J 8:1161-1178.
52. Dematteis M, Julien C, Guillermet C, Sturm N, Lantuejoul S, Mallaret M, Lévy P, Gozal E. 2008. Intermittent hypoxia induces early functional cardiovascular remodeling in mice. Am J Respir Crit Care Med 177:227-235.
53. Dick TE, Hsieh YH, Wang N, Prabhakar N. 2007. Acute intermittent hypoxia increases both phrenic and sympathetic nerve activities in the rat. Exp Physiol 92:87-97.
54. Dong JW, Zhu HF, Zhu WZ, Ding HL, Ma TM, Zhou ZN. 2003. Intermittent hypoxia attenuates ischemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression. Cell Res 13:385-391.
55. Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G. 2005. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172:613-618.
56. Dyugovskaya L, Polyakov A, Lavie P, Lavie L. 2008. Delayed neutrophil apoptosis in patients with sleep apnea. Am J Respir Crit Care Med 177:544-554.
57. Engleman HM, Martin SE, Deary IJ, Douglas NJ. 1994. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/ hypopnoea syndrome. Lancet 343:572-575.
58. Fan C, Iacobas DA, Zhou D, Chen Q, Lai JK, Gavrialov O, Haddad GG. 2005. Gene expression and phenotypic characterization of mouse heart after chronic constant or intermittent hypoxia. Physiol Genomics 22:292-307.
59. Farré R, Nácher M, Serrano-Mollar A, Gáldiz JB, Alvarez FJ, Navajas D, Montserrat JM. 2007. Rat model of chronic recurrent airway obstructions to study the sleep apnea syndrome. Sleep 30:930-933.
60. Farré R, Rotger M, Montserrat JM, Calero G, Navajas D. 2003. Collapsible upper airway segment to study the obstructive sleep apnea/hypopnea syndrome in rats. Respir Physiol Neurobiol 136:199-209.
61. Fewell JE, Williams BJ, Szabo JS, Taylor BJ. 1988. Influence of repeated upper airway obstruction on the arousal and cardiopulmonary response to upper airway obstruction in lambs. Pediatr Res 23:191-195.
62. Fletcher EC. 2001. Invited review: Physiological consequences of intermittent hypoxia: systemic blood pressure. J Appl Physiol 90:1600-1605.
63. Fletcher EC, Lesske J, Behm R, Miller CC 3rd, Stauss H, Unger T. 1992a. Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea. J Appl Physiol 72:1978-1984.
64. Fletcher EC, Lesske J, Culman J, Miller CC, Unger T. 1992b. Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension 20:612-619.
65. Fletcher EC, Lesske J, Qian W, Miller CC 3rd, Unger T. 1992c. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19:555-561.
66. Fletcher EC, Bao G, Miller CC 3rd. 1995. Effect of recurrent episodic hypocapnic, eucapnic, and hypercapnic hypoxia on systemic blood pressure. J Appl Physiol 78:1516-1521.
67. Fletcher EC, Bao G, Li R. 1999. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34:309-314.
68. Fletcher EC, Orolinova N, Bader M. 2002. Blood pressure response to chronic episodic hypoxia: The renin-angiotensin system. J Appl Physiol 92:627-633.
69. Foster GE, Poulin MJ, Hanly PJ. 2007. Intermittent hypoxia and vascular function: Implications for obstructive sleep apnoea. Exp Physiol 92:51-65.
70. Gami AS, Howard DE, Olson EJ, Somers VK. 2005. Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 352:1206-1214.
71. Gao Y, Gao G, Long C, Han S, Zu P, Fang L, Li J. 2006. Enhanced phosphorylation of cyclic AMP response element binding protein in the brain of mice following repetitive hypoxic exposure. Biochem Biophys Res Commun 340:661-667.
72. Garrigue S, Pépin JL, Defaye P, Murgatroyd F, Poezevara Y, Clémenty J, Lévy P. 2007. High prevalence of sleep apnea syndrome in patients with long-term pacing: The European Multicenter Polysomnographic Study. Circulation 115:1703-1709.
73. Gay P, Weaver T, Loube D, Iber C; Positive Airway Pressure Task Force; Standards of Practice Committee; American Academy of Sleep Medicine. 2006. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep 29:381-401.
74. Goettsch W, Lattmann T, Amann K, Szibor M, Morawietz H, Münter K, Müller SP, Shaw S, Barton M. 2001. Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: Implications for atherosclerosis. Biochem Biophys Res Commun 280:908-913.
75. Gozal D, Daniel JM, Dohanich GP. 2001. Behavioral and anatomical correlates of chronic episodic hypoxia during sleep in the rat. J Neurosci 21:2442-2450.
76. Gozal E, Sachleben LR Jr, Rane MJ, Vega C, Gozal D. 2005a. Mild sustained and intermittent hypoxia induce apoptosis in PC-12 cells via different mechanisms. Am J Physiol Cell Physiol 288:C535-C542.
77. Gozal E, Shah ZA, Pequignot JM, Pequignot J, Sachleben LR, CzyzykKrzeska MF, Li RC, Guo SZ, Gozal D. 2005b. Tyrosine hydroxylase expression and activity in the rat brain: Differential regulation after long-term intermittent or sustained hypoxia. J Appl Physiol 99:642-649.
78. Greenberg HE, Sica A, Batson D, Scharf SM. 1999a. Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J Appl Physiol 86:298-305.
79. Greenberg HE, Sica AL, Scharf SM, Ruggiero DA. 1999b. Expression of c-Fos in the rat brainstem after chronic intermittent hypoxia. Brain Res 816:638-645.
80. Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF. 2006. Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343:591-596.
81. Guyenet PG. 2006. The sympathetic control of blood pressure. Nat Rev Neurosci 7:335-346.
82. Guzman-Marin R, Bashir T, Suntsova N, Szymusiak R, McGinty D. 2007. Hippocampal neurogenesis is reduced by sleep fragmentation in the adult rat. Neuroscience 148:325-333.
83. Haentjens P, Van Meerhaeghe A, Moscariello A, De Weerdt S, Poppe K, Dupont A, Velkeniers B. 2007. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome: Evidence from a meta-analysis of placebo-controlled randomized trials. Arch Intern Med 167:757-764.
84. Hamrahi H, Chan B, Horner RL. 2001. On-line detection of sleep-wake states and application to produce intermittent hypoxia only in sleep in rats. J Appl Physiol 90:2130-2140.
85. Hansson GK, Libby P. 2006. The immune response in atherosclerosis: A double-edged sword. Nat Rev Immunol 6:508-519.
86. Hausenloy DJ, Yellon DM. 2008a. Remote ischaemic preconditioning: Underlying mechanisms and clinical application. Cardiovasc Res 79:377-386.
87. Hausenloy DJ, Yellon DM. 2008b. Preconditioning and postconditioning: Underlying mechanisms and clinical application. Atherosclerosis, doi:10.1016/j.atherosclerosis.2008.10.029.
88. Hayashi T, Yamashita C, Matsumoto C, Kwak CJ, Fujii K, Hirata T, Miyamura M, Mori T, Ukimura A, Okada Y, Matsumura Y, Kitaura Y. 2008. Role of gp91phox-containing NADPH oxidase in left ventricular remodeling induced by intermittent hypoxic stress. Am J Physiol Heart Circ Physiol 294:H2197-H2203.
89. Hendricks JC, Kline LR, Kovalski RJ, O'Brien JA, Morrison AR, Pack AI. 1987. The English bulldog: A natural model of sleep-disordered breathing. J Appl Physiol 63:1344-1350.
90. Hoffstein V, Herridge M, Mateika S, Redline S, Strohl KP. 1994. Hematocrit levels in sleep apnea. Chest 106:787-791.
91. Hofker MH, van Vlijmen BJ, Havekes LM. 1998. Transgenic mouse models to study the role of APOE in hyperlipidemia and atherosclerosis. Atherosclerosis 137:1-11.
92. Huang P, Qi Z, Bu X, Zhang N, Han S, Fang L, Li J. 2007. Neuron-specific phosphorylation of mitogen- and stress-activated protein kinase-1 involved in cerebral hypoxic preconditioning of mice. J Neurosci Res 85:1279-1287.
93. Hui AS, Striet JB, Gudelsky G, Soukhova GK, Gozal E, Beitner-Johnson D, Guo SZ, Sachleben LR Jr, Haycock JW, Gozal D, Czyzyk-Krzeska MF. 2003. Regulation of catecholamines by sustained and intermittent hypoxia in neuroendocrine cells and sympathetic neurons. Hypertension 42:1130-1136.
94. Imadojemu VA, Gleeson K, Quraishi SA, Kunselman AR, Sinoway LI, Leuenberger UA. 2002. Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. Am J Respir Crit Care Med 165:950-953.
95. Jenkinson C, Davies RJ, Mullins R, Stradling JR. 1999. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: A randomised prospective parallel trial. Lancet 353:2100-2105.
96. Joyeux-Faure M, Stanke-Labesque F, Lefebvre B, Béguin P, Godin-Ribuot D, Ribuot C, Launois SH, Bessard G, Lévy P. 2005. Chronic intermittent hypoxia increases infarction in the isolated rat heart. J Appl Physiol 98:1691-1696.
97. Julien C, Bayat S, Lévy P. 2003. Vascular reactivity to norepinephrine and acetylcholine after chronic intermittent hypoxia in mice. Respir Physiol Neurobiol 139:21-32.
98. Jun J, Polotsky VY. 2009. Metabolic consequences of sleep-disordered breathing. ILAR J 50:289-306.
99. Jun JC, Savransky V, Nannayakara, A, Bevans S, Li J, Polotsky V. 2008. Intermittent hypoxia accelerates aortic atherosclerosis in ApoE deficient mice. Am J Resp Crit Care Med 177:A291.
100. Jung ME, Simpkins JW, Wilson AM, Downey HF, Mallet RT. 2008. Intermittent hypoxia conditioning prevents behavioral deficit and brain oxidative stress in ethanol-withdrawn rats. J Appl Physiol 105:510-517.
101. Kalaria RN, Spoors L, Laude EA, Emery CJ, Thwaites-Bee D, Fairlie J, Oakley AE, Barer DH, Barer GR. 2004. Hypoxia of sleep apnoea: Cardiopulmonary and cerebral changes after intermittent hypoxia in rats. Respir Physiol Neurobiol 140:53-62.
102. Kanagy NL. 2009. Vascular effects of intermittent hypoxia. ILAR J 50:282-288.
103. Kanagy NL, Walker BR, Nelin LD. 2001. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 37:511-515.
104. 2 reserve in sleeping dogs. J Appl Physiol 103:1942-1949.
105. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V, Somers VK. 2000. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102:2607-2610.
106. Kimoff RJ, Brooks D, Horner RL, Kozar LF, Render-Teixeira CL, Champagne V, Mayer P, Phillipson EA. 1997. Ventilatory and arousal responses to hypoxia and hypercapnia in a canine model of obstructive sleep apnea. Am J Respir Crit Care Med 156:886-894.
107. Kimoff RJ, Makino H, Horner RL, Kozar LF, Lue F, Slutsky AS, Phillipson EA. 1994. Canine model of obstructive sleep apnea: Model description and preliminary application. J Appl Physiol 76:1810-1817.
108. Klein JB, Barati MT, Wu R, Gozal D, Sachleben LR Jr, Kausar H, Trent JO, Gozal E, Rane MJ. 2005. Akt-mediated valosin-containing protein 97 phosphorylation regulates its association with ubiquitinated proteins. J Biol Chem 280:31870-31881.
109. Kolář F, Oš?ádal B. 2004. Molecular mechanisms of cardiac protection by adaptation to chronic hypoxia. Physiol Res 53:S3-S13.
110. Kraiczi H, Magga J, Sun XY, Ruskoaho H, Zhao X, Hedner J. 1999. Hypoxic pressor response, cardiac size, and natriuretic peptides are modified by long-term intermittent hypoxia. J Appl Physiol 87:2025-2031.
111. Kraiczi H, Hedner J, Peker Y, Carlson J. 2000. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 89:493-498.
112. Kumar GK, Kim DK, Lee MS, Ramachandran R, Prabhakar NR. 2003. Activation of tyrosine hydroxylase by intermittent hypoxia: Involvement of serine phosphorylation. J Appl Physiol 95:536-544.
113. Kumar GK, Rai V, Sharma SD, Ramakrishnan DP, Peng YJ, Souvannakitti D, Prabhakar NR. 2006. Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol 575:229-239.
114. Kuri BA, Khan SA, Chan SA, Prabhakar NR, Smith CB. 2007. Increased secretory capacity of mouse adrenal chromaffin cells by chronic intermittent hypoxia: Involvement of protein kinase C. J Physiol 584:313-319.
115. Lai CJ, Yang CC, Hsu YY, Lin YN, Kuo TB. 2006. Enhanced sympathetic outflow and decreased baroreflex sensitivity are associated with intermittent hypoxia-induced systemic hypertension in conscious rats. J Appl Physiol 100:1974-1982.
116. Lattimore JD, Wilcox I, Nakhla S, Langenfeld M, Jessup W, Celermajer DS. 2005. Repetitive hypoxia increases lipid loading in human macrophages: A potentially atherogenic effect. Atherosclerosis 179:255-259.
117. Lavie P. 2007. Mortality in sleep apnoea syndrome: A review of the evidence. Eur Resp Rev 16:203-210.
118. Lavie L. 2009. Oxidative stress: A unifying paradigm in obstructive sleep apnea and comorbidities. Prog Cardiovasc Dis 51:303-312.
119. Lavie L, Lavie P. 2006. Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea. Med Hypotheses 66:1069-1073.
120. Lavie P, Lavie L, Herer P. 2005. All-cause mortality in males with sleep apnoea syndrome: Declining mortality rates with age. Eur Respir J 25:514-520.
121. Launois SH, Abraham JH, Weiss JW, Kirby DA. 1998. Patterned cardiovascular responses to sleep and nonrespiratory arousals in a porcine model. J Appl Physiol 85:1285-1291.
122. Launois SH, Averill N, Abraham JH, Kirby DA, Weiss JW. 2001. Cardiovascular responses to nonrespiratory and respiratory arousals in a porcine model. J Appl Physiol 90:114-120.
123. Lefebvre B, Godin-Ribuot D, Joyeux-Faure M, Caron F, Bessard G, Lévy P, Stanke-Labesque F. 2006. Functional assessment of vascular reactivity after chronic intermittent hypoxia in the rat. Respir Physiol Neurobiol 150:278-286.
124. Lee AJ, Mowbray PI, Lowe GD, Rumley A, Fowkes FG, Allan PL. 1998. Blood viscosity and elevated carotid intima-media thickness in men and women: The Edinburgh Artery Study. Circulation 97:1467-1473.
125. Lee EJ, Woodske ME, Zou B, O'Donnell CP. 2008. Dynamic arterial blood gas analysis in conscious, unrestrained C57BL/6J mice during exposure to intermittent hypoxia. J Appl Physiol, doi:10.1152/japplphysiol.91255.2008.
126. Lesske J, Fletcher EC, Bao G, Unger T. 1997. Hypertension caused by chronic intermittent hypoxia: Influence of chemoreceptors and sympathetic nervous system. J Hypertens 15:1593-1603.
127. Leung RS, Bradley TD. 2001. Sleep apnea and cardiovascular disease. Am J Respir Crit Care Med 164:2147-2165.
128. Li J, Niu C, Han S, Zu P, Li H, Xu Q, Fang L. 2005. Identification of protein kinase C isoforms involved in cerebral hypoxic preconditioning of mice. Brain Res 1060:62-72.
129. Li R, Bao G, el-Mallakh RS, Fletcher EC. 1996. Effects of chronic episodic hypoxia on monoamine metabolism and motor activity. Physiol Behav 60:1071-1076.
130. Lin M, Liu R, Gozal D, Wead WB, Chapleau MW, Wurster R, Cheng ZJ. 2007. Chronic intermittent hypoxia impairs baroreflex control of heart rate but enhances heart rate responses to vagal efferent stimulation in anesthetized mice. Am J Physiol Heart Circ Physiol 293:H997-H1006.
131. Lin M, Ai J, Li L, Huang C, Chapleau MW, Liu R, Gozal D, Wead WB, Wurster RD, Cheng ZJ. 2008. Structural remodeling of nucleus ambiguus projections to cardiac ganglia following chronic intermittent hypoxia in C57BL/6J mice. J Comp Neurol 509:103-117.
132. Liu Y, Ji ES, Xiang S, Tamisier R, Tong J, Huang J, Weiss JW. 2009. Exposure to cyclic intermittent hypoxia increases expression of functional NMDA receptors in the rat carotid body. J Appl Physiol 106:259-267.
133. Logan AG, Tkacova R, Perlikowski SM, Leung RS, Tisler A, Floras JS, Bradley TD. 2003. Refractory hypertension and sleep apnoea: Effect of CPAP on blood pressure and baroreflex. Eur Respir J 21:241-247.
134. Lonergan RP 3rd, Ware JC, Atkinson RL, Winter WC, Suratt PM. 1998. Sleep apnea in obese miniature pigs. J Appl Physiol 84:531-536.
135. Long C, Gao Y, Gao G, Han S, Zu P, Fang L, Li J. 2006. Decreased phosphorylation and protein expression of ERK1/2 in the brain of hypoxic preconditioned mice. Neurosci Lett 397:307-312.
136. Lu GW, Liu HY. 2001. Downregulation of nitric oxide in the brain of mice during their hypoxic preconditioning. J Appl Physiol 91:1193-1198.
137. Machaalani R, Waters KA. 2003. Increased neuronal cell death after intermittent hypercapnic hypoxia in the developing piglet brainstem. Brain Res 985:127-134.
138. Malhotra A, White DP. 2002. Obstructive sleep apnoea. Lancet 360:237-245.
139. Marin JM, Carrizo SJ, Vicente E, Agusti AG. 2005. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study. Lancet 365:1046-1053.
140. McCoy JG, Tartar JL, Bebis AC, Ward CP, McKenna JT, Baxter MG, McGaughy J, McCarley RW, Strecker RE. 2007. Experimental sleep fragmentation impairs attentional set-shifting in rats. Sleep 30:52-60.
141. McGuire M, Bradford A. 1999. Chronic intermittent hypoxia increases haematocrit and causes right ventricular hypertrophy in the rat. Respir Physiol 117:53-58.
142. McGuire M, Bradford A. 2001. Chronic intermittent hypercapnic hypoxia increases pulmonary arterial pressure and haematocrit in rats. Eur Respir J 18:279-285.
143. Meerson FZ, Malyshev IY. 1989. Adaptation to stress increases the heart resistance to ischemic and reperfusion arrhythmias. J Mol Cell Cardiol 21:299-303.
144. Meerson FZ, Ustinova EE, Orlova EH. 1987. Prevention and elimination of heart arrhythmias by adaptation to intermittent high altitude hypoxia. Clin Cardiol 10:783-789.
145. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, Sahadevan J, Redline S; Sleep Heart Health Study. 2006. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med 173:910-916.
146. Mendelson WB, Martin JV, Perlis M, Giesen H, Wagner R, Rapoport SI. 1988. Periodic cessation of respiratory effort during sleep in adult rats. Physiol Behav 43:229-234.
147. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N, Okada S, Ohta S, Naito H, Adachi M. 2005. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172:625-630.
148. Montserrat JM, Ferrer M, Hernandez L, Farré R, Vilagut G, Navajas D, Badia JR, Carrasco E, De Pablo J, Ballester E. 2001. Effectiveness of CPAP treatment in daytime function in sleep apnea syndrome: A randomized controlled study with an optimized placebo. Am J Respir Crit Care Med 164:608-613.
149. Morgan BJ. 2007. Vascular consequences of intermittent hypoxia. Adv Exp Med Biol 618:69-84.
150. Nácher M, Serrano-Mollar A, Farré R, Panés J, Seguí J, Montserrat JM. 2007. Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea. Respir Physiol Neurobiol 155:93-96.
151. Neckář J, Szárszoi O, Koten L, Papoušek F, Oš?ádal B, Grover GJ, Kolář F. 2002. Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats. Cardiovasc Res 55:567-575.
152. Neubauer JA. 2001. Physiological and pathophysiological responses to intermittent hypoxia. J Appl Physiol 90:1593-1599.
153. Niu C, Li J, Cui X, Han S, Zu P, Li H, Xu Q. 2005. Changes in cPKC isoform-specific membrane translocation and protein expression in the brain of hypoxic preconditioned mice. Neurosci Lett 384:1-6.
154. Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H, Ouchi Y. 1999. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87:10-14.
155. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y. 2003. Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94:179-184.
156. Park AM, Nagase H, Vinod Kumar S, Suzuki YJ. 2007. Acute intermittent hypoxia activates myocardial cell survival signaling. Am J Physiol Heart Circ Physiol 292:H751-H757.
157. Park AM, Suzuki YJ. 2007. Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice. J Appl Physiol 102:1806-1814.
158. Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. 2003. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: Results of a meta-analysis. Arch Intern Med 163:565-571.
159. Peng YJ, Overholt JL, Kline D, Kumar GK, Prabhakar NR. 2003. Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: Implications for recurrent apneas. Proc Natl Acad Sci U S A 100:10073-10078.
160. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, Semenza GL, Prabhakar NR. 2006. Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 577:705-716.
161. Pépin JL, Lévy P, Garcin A, Feuerstein C, Savasta M. 1996. Effects of longterm hypoxia on tyrosine hydroxylase protein content in catecholaminergic rat brainstem areas: A quantitative autoradiographic study. Brain Res 733:1-8.
162. Peppard PE, Young T, Palta M, Skatrud J. 2000. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378-1384.
163. Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJ. 2002. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep
164. Pernow J, Wang QD. 1997. Endothelin in myocardial ischaemia and reperfusion. Cardiovasc Res 33:518-526.
165. Philip P, Gross CE, Taillard J, Bioulac B, Guilleminault C. 2005. An animal model of a spontaneously reversible obstructive sleep apnea syndrome in the monkey. Neurobiol Dis 20:428-431.
166. Phillips SA, Olson EB, Morgan BJ, Lombard JH. 2004. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286:H388-H393.
167. Pinto JM, Garpestad E, Weiss JW, Bergau DM, Kirby DA. 1993. Hemodynamic changes associated with obstructive sleep apnea followed by arousal in a porcine model. J Appl Physiol 75:1439-1443.
168. Piot C, Croisille P, Staat P, Thibault H, Rioufol G, Mewton N, Elbelghiti R, Cung TT, Bonnefoy E, Angoulvant D, Macia C, Raczka F, Sportouch C, Gahide G, Finet G, André-Fouët X, Revel D, Kirkorian G, Monassier JP, Derumeaux G, Ovize M. 2008. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359:473-481.
169. Polotsky VY, Rubin AE, Balbir A, Dean T, Smith PL, Schwartz AR, O'Donnell CP. 2006. Intermittent hypoxia causes REM sleep deficits and decreases EEG delta power in NREM sleep in the C57BL/6J mouse. Sleep Med 7:7-16.
170. Poupa O, Krofta K, Prochazka J, Turek Z. 1966. Acclimation to simulated high altitude and acute cardiac necrosis. Fed Proc 25:1243-1246.
171. Prabhakar NR. 2001. Oxygen sensing during intermittent hypoxia: Cellular and molecular mechanisms. J Appl Physiol 90:1986-1994.
172. Prabhakar NR, Peng YJ, Jacono FJ, Kumar GK, Dick TE. 2005. Cardiovascular alterations by chronic intermittent hypoxia: importance of carotid body chemoreflexes. Clin Exp Pharmacol Physiol 32:447-449.
173. Prabhakar NR, Dick TE, Nanduri J, Kumar GK. 2007. Systemic, cellular and molecular analysis of chemoreflex-mediated sympathoexcitation by chronic intermittent hypoxia. Exp Physiol 92:39-44.
174. Ramond A, Samuel JL, Tonini J, Sanchez H, Ribuot C, Lévy P, Godin-Ribuot D, Joyeux-Faure M. 2008. Effect of chronic intermittent hypoxia on cardiac angiogenesis and mitochondrial function. Fund Clin Pharmacol 22:52.
175. Ran R, Xu H, Lu A, Bernaudin M, Sharp FR. 2005. Hypoxia preconditioning in the brain. Dev Neurosci 27:87-92.
176. Ray CJ, Abbas MR, Coney AM, Marshall JM. 2002. Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation: in vivo and in vitro studies. J Physiol 544:195-209.
177. Rey S, Del Rio R, Alcayaga J, Iturriaga R. 2004. Chronic intermittent hypoxia enhances cat chemosensory and ventilatory responses to hypoxia. J Physiol 560:577-586.
178. Rey S, Del Rio R, Iturriaga R. 2008. Contribution of endothelin-1 and endothelin A and B receptors to the enhanced carotid body chemosensory responses induced by chronic intermittent hypoxia. Adv Exp Med Biol 605:228-232.
179. Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR. 2004. Circulating cardiovascular risk factors in obstructive sleep apnoea: Data from randomised controlled trials. Thorax 59:777-782
180. Rubin AE, Polotsky VY, Balbir A, Krishnan JA, Schwartz AR, Smith PL, Fitzgerald RS, Tankersley CG, Shirahata M, O'Donnell CP. 2003. Differences in sleep-induced hypoxia between A/J and DBA/2J mouse strains. Am J Respir Crit Care Med 168:1520-1527.
181. Ryan S, Taylor CT, McNicholas WT. 2005. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660-2667.
182. Rybnikova E, Sitnik N, Gluschenko T, Tjulkova E, Samoilov MO. 2006. The preconditioning modified neuronal expression of apoptosis-related proteins of Bcl-2 superfamily following severe hypobaric hypoxia in rats. Brain Res 1089:195-202.
183. Rybnikova E, Gluschenko T, Tulkova E, Churilova A, Jaroshevich O, Baranova K, Samoilov M. 2008. Preconditioning induces prolonged expression of transcription factors pCREB and NF-kappa B in the neocortex of rats before and following severe hypobaric hypoxia. J Neurochem 106:1450-1458.
184. Sasaki H, Fukuda S, Otani H, Zhu L, Yamaura G, Engelman RM, Das DK, Maulik N. 2002. Hypoxic preconditioning triggers myocardial angio-genesis: A novel approach to enhance contractile functional reserve in rat with myocardial infarction. J Mol Cell Cardiol 34:335-348.
185. Savransky V, Nanayakkara A, Li J, Bevans S, Smith PL, Rodriguez A, Polotsky VY. 2007. Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175:1290-1297.
186. Savransky V, Jun J, Li J, Nanayakkara A, Fonti S, Moser AB, Steele KE, Schweitzer MA, Patil SP, Bhanot S, Schwartz AR, Polotsky VY. 2008. Dyslipidemia and atherosclerosis induced by chronic intermittent hypoxia are attenuated by deficiency of stearoyl coenzyme A desaturase. Circ Res 103:1173-1180.
187. Scharf SM, Graver LM, Balaban K. 1992. Cardiovascular effects of periodic occlusions of the upper airways in dogs. Am Rev Respir Dis 146:321-329.
188. Schömig A, Richardt G. 1990. The role of catecholamines in ischemia. J Cardiovasc Pharmacol 16:S105-S112.
189. Serebrovskaya TV. 2002. Intermittent hypoxia research in the former Soviet Union and the Commonwealth of Independent States: History and review of the concept and selected applications. High Alt Med Biol 3:205-221.
190. Serebrovskaya TV, Swanson RJ, Kolesnikova EE. 2003. Intermittent hypoxia: Mechanisms of action and some applications to bronchial asthma treatment. J Physiol Pharmacol 54:35-41.
191. Serebrovskaya TV, Manukhina EB, Smith ML, Downey HF, Mallet RT. 2008. Intermittent hypoxia: Cause of or therapy for systemic hypertension? Exp Biol Med 233:627-650.
192. Semenza GL. 1999. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15:551-578.
193. Serviddio G, Di Venosa N, Federici A, D'Agostino D, Rollo T, Prigigallo F, Altomare E, Fiore T, Vendemiale G. 2005. Brief hypoxia before normoxic reperfusion (postconditioning) protects the heart against ischemia-reperfusion injury by preventing mitochondria peroxyde production and glutathione depletion. FASEB J 19:354-361.
194. Shao G, Gao CY, Lu GW. 2005. Alterations of hypoxia-inducible factor-1 alpha in the hippocampus of mice acutely and repeatedly exposed to hypoxia. Neurosignals 14:255-261.
195. Scharf SM, Graver LM, Balaban K. 1992. Cardiovascular effects of periodic occlusions of the upper airways in dogs. Am Rev Respir Dis 146:321-329.
196. Sica AL, Greenberg HE, Scharf SM, Ruggiero DA. 2000a. Immediate-early gene expression in cerebral cortex following exposure to chronicin-termittent hypoxia. Brain Res 870:204-210.
197. Sica AL, Greenberg HE, Scharf SM, Ruggiero DA. 2000b. Chronicintermittent hypoxia induces immediate early gene expression in the midline thalamus and epithalamus. Brain Res 883:224-228.
198. Snoeckx LH, Cornelussen RN, Van Nieuwenhoven FA, Reneman RS, Van Der Vusse GJ. 2001. Heat shock proteins and cardiovascular pathophysiology. Physiol Rev 81:1461-1497.
199. Somers VK, Mark AL, Abboud FM. 1991. Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest 87:1953-1957.
200. Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, Daniels S, Floras JS, Hunt CE, Olson LJ, Pickering TG, Russell R, Woo M, Young T; American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology; American Heart Association Stroke Council; American Heart Association Council on Cardiovascular Nursing; American College of Cardiology Foundation. 2008. Sleep apnea and cardiovascular disease: An American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing; in collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118:1080-1111.
201. Soukhova-O'Hare GK, Cheng ZJ, Roberts AM, Gozal D. 2006. Postnatal intermittent hypoxia alters baroreflex function in adult rats. Am J Physiol Heart Circ Physiol 290:H1157-H164.
202. Steffens S, Burger F, Pelli G, Dean Y, Elson G, Kosco-Vilbois M, Chatenoud L, Mach F. 2006. Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice. Circulation 114:1977-1984.
203. Steiger HJ, Hänggi D. 2007. Ischaemic preconditioning of the brain, mechanisms and applications. Acta Neurochir 149:1-10.
204. Steiner S, Jax T, Evers S, Hennersdorf M, Schwalen A, Strauer BE. 2005. Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 104:92-96.
205. Stroev SA, Gluschenko TS, Tjulkova EI, Rybnikova EA, Samoilov MO, Pelto-Huikko M. 2005. The effect of preconditioning on the Cu, Zn superoxide dismutase expression and enzyme activity in rat brain at the early period after severe hypobaric hypoxia. Neurosci Res 53:39-47
206. 2+ overload. Am J Physiol Heart Circ Physiol 288:H1900-H1908.
207. Suzuki M, Guilleminault C, Otsuka K, Shiomi T. 1996. Blood pressure "dipping" and "non-dipping" in obstructive sleep apnea syndrome patients. Sleep 19:382-387.
208. Tagaito Y, Polotsky VY, Campen MJ, Wilson JA, Balbir A, Smith PL, Schwartz AR, O'Donnell CP. 2001. A model of sleep-disordered breathing in the C57BL/6J mouse. J Appl Physiol 91:2758-2766.
209. Tahawi Z, Orolinova N, Joshua IG, Bader M, Fletcher EC. 2001. Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. J Appl Physiol 90:2007-2013.
210. Tamisier R, Remy J, Launois SH, Pépin JL, Baguet JP, Lévy P. 2007. Fourteen days of nocturnal intermittent hypoxia induce increases in muscle sympathetic nerve activity (MSNA) and arterial blood pressure (BP) in normal humans. Am J Resp Crit Care Med 175:A756.
211. Tamisier R, Gilmartin GS, Launois SH, Pépin JL, Nespoulet H, Thomas RJ, Lévy P, Weiss JW. 2009. A new model of chronic intermittent hypoxia in humans: Effect on ventilation, sleep and blood pressure. J Appl Physiol, doi:10.1152/japplphysiol.91165.2008.
212. Thomas BJ, Wanstall JC. 2003. Alterations in pulmonary vascular function in rats exposed to intermittent hypoxia. Eur J Pharmacol 477:153-161.
213. Troncoso Brindeiro CM, da Silva AQ, Allahdadi KJ, Youngblood V, Kanagy NL. 2007. Reactive oxygen species contribute to sleep apnea-induced hypertension in rats. Am J Physiol Heart Circ Physiol 293:H2971-H2976.
214. Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser H, Schwartz MA. 2005. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437:426-431.
215. van Buul JD, Hordijk PL. 2004. Signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol 24:824-833.
216. Veasey S. 2009. Insight from animal models into the cognitive consequences of adult sleep-disordered breathing. ILAR J 50:307-311.
217. Veasey SC, Panckeri KA, Hoffman EA, Pack AI, Hendricks JC. 1996. The effects of serotonin antagonists in an animal model of sleep-disordered breathing. Am J Respir Crit Care Med 153:776-786.
218. Veasey SC, Fenik P, Panckeri K, Pack AI, Hendricks JC. 1999. The effects of trazodone with L-tryptophan on sleep-disordered breathing in the English bulldog. Am J Respir Crit Care Med 160:1659-1667.
219. Veasey SC, Chachkes J, Fenik P, Hendricks JC. 2001. The effects of ondansetron on sleep-disordered breathing in the English bulldog. Sleep 24:155-160.
220. Veasey SC, Davis CW, Fenik P, Zhan G, Hsu YJ, Pratico D, Gow A. 2004. Long-term intermittent hypoxia in mice: Protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep 27:194-201.
221. Veillard NR, Kwak B, Pelli G, Mulhaupt F, James RW, Proudfoot AE, Mach F. 2004. Antagonism of RANTES receptors reduces atherosclerotic plaque formation in mice. Circ Res 94:253-261.
222. Wang HC, Zhang HF, Guo WY, Su H, Zhang KR, Li QX, Yan W, Ma XL, Lopez BL, Christopher TA, Gao F. 2006. Hypoxic postconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: Role of peroxynitrite formation. Apoptosis 11:1453-1460.
223. Wang QD, Pernow J, Sjöquist PO, Rydén L. 2002. Pharmacological possibilities for protection against myocardial reperfusion injury. Cardiovasc Res 55:25-37.
224. Weaver TE, Grunstein RR. 2008. Adherence to continuous positive airway pressure therapy: The challenge to effective treatment. Proc Am Thorac Soc 5:173-178.
225. Weiss JW, Remsburg S, Garpestad E, Ringler J, Sparrow D, Parker JA. 1996. Hemodynamic consequences of obstructive sleep apnea. Sleep 19:388-397.
226. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. 2007. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 62:969-974.
227. White SG, Fletcher EC, Miller CC 3rd. 1995. Acute systemic blood pressure elevation in obstructive and nonobstructive breath hold in primates. J Appl Physiol 79:324-330.
228. L, Tekin D, Gursoy E, Salloum F, Levasseur JE, Kukreja RC. 2002. Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia. Am J Physiol Heart Circ Physiol 283:H5-H12.
229. Yamashita K, Discher DJ, Hu J, Bishopric NH, Webster KA. 2001. Molecular regulation of the endothelin-1 gene by hypoxia: Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, and p300/ CBP. J Biol Chem 276:12645-12653.
230. Yan B, Soukhova-O'Hare GK, Li L, Lin Y, Gozal D, Wead WB, Wurster RD, Cheng ZJ. 2008. Attenuation of heart rate control and neural degeneration in nucleus ambiguus following chronic intermittent hypoxia in young adult Fischer 344 rats. Neuroscience 153:709-720.
231. Yellon DM, Dana A. 2000. The preconditioning phenomenon: A tool for the scientist or a clinical reality? Circ Res 87:543-550.
232. Yellon DM, Downey JM. 2003. Preconditioning the myocardium: From cellular physiology to clinical cardiology. Physiol Rev 83:1113-1151.
233. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. 1993. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230-1235.
234. Young T, Peppard PE, Gottlieb DJ. 2002. Epidemiology of obstructive sleep apnea: A population health perspective. Am J Respir Crit Care Med 165:1217-1239.
235. Ytrehus K. 2000. The ischemic heart: Experimental models. Pharmacol Res 42:193-203.
236. Zhan G, Fenik P, Pratico D, Veasey SC. 2005a. Inducible nitric oxide synthase in long-term intermittent hypoxia: Hypersomnolence and brain injury. Am J Respir Crit Care Med 171:1414-1420.
237. Zhan G, Serrano F, Fenik P, Hsu R, Kong L, Pratico D, Klann E, Veasey SC. 2005b. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 172:921-929.
238. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258:468-471.
239. Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J. 2003. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285:H579-H588.
240. Zhu Y, Fenik P, Zhan G, Mazza E, Kelz M, Aston-Jones G, Veasey SC. 2007. Selective loss of catecholaminergic wake active neurons in a murine sleep apnea model. J Neurosci 27:10060-10071.
241. Zoccal DB, Bonagamba LG, Oliveira FR, Antunes-Rodrigues J, Machado BH. 2007. Increased sympathetic activity in rats submitted to chronic intermittent hypoxia. Exp Physiol 92:79-85.
242. Zoccal DB, Simms AE, Bonagamba LG, Braga VA, Pickering AE, Paton JF, Machado BH. 2008. Increased sympathetic outflow in juvenile rats submitted to chronic intermittent hypoxia correlates with enhanced expiratory activity. J Physiol 586:3253-3265.